Salmon Evolution entered its Q3 2026 report with the stock under pressure, down roughly 30% over the past three months and closing at NOK2.86 on 28 October. The company then reported another quarterly loss, with net income excluding extra items at a deficit of NOK25.7m, yet the headline story sits elsewhere. Harvest volumes and revenue reached NOK104.9m, a clear step up in scale that clashes with the weak share price trend. For investors, the expectation gap now centers on one issue: the margin squeeze is still real, even as the farming engine gets bigger.
Love the scale Salmon Evolution is starting to show but worried about the ongoing margin squeeze and quarterly losses? Compare this setup against other aquaculture and food producers in our list of solid balance sheet and fundamentals stocks (203 results)
Q3 2026 Earnings Summary
- Total Revenue, Q3 2026 vs. Q3 2025: NOK104.9m vs. NOK86.5m (up roughly 21%)
- Net Loss, Q3 2026 vs. Q3 2025: NOK25.7m loss vs. NOK46.3m loss (loss narrowed by around 44%)
- Basic EPS, Q3 2026 vs. Q3 2025: NOK0.05 loss per share vs. NOK0.10 loss per share (per share loss reduced by about half)
- Harvest Volume, Q3 2026: approximately 1,597 tonnes gutted weight, with revenue reflecting increased scale in Salmon Evolution’s farming operations
Management is betting Phase 2 scale will reset unit economics. Ask Charlie what Salmon Evolution’s Phase 2 scale means for costs.
Salmon Evolution: Progress On Scale, Lag In Profitability
Bulls argue Salmon Evolution can turn Indre Harøy into a much larger, more efficient engine as Phase 2 fills up and biology improves.
"The key factor is that rising volumes from Phases 1 and 2 at Indre Harøy continue to dilute the roughly NOK 200m fixed cost base, while recent gains in farming costs and feed efficiency are sustained."
Q3 gives partial support to that idea. Harvest volume of about 1,597 tonnes and farming cost near NOK 71/kg, with underlying cost around NOK 68/kg, shows fixed costs starting to spread over more kilos and unit costs moving lower. Group EBITDA of NOK 20m loss and farming EBITDA of NOK 13.3m loss, along with reduced 2026 harvest guidance, signal the efficiency story is not yet translating into earnings.
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.
Salmon Evolution Bear Case: Scale Progress, Milestones Missed
The worry is that Salmon Evolution never quite converts installed capacity into the volume needed to fix earnings.
"If utilization stalls below plans or the planned stocking of around 2.8 million smolt in 2026 is not followed by sustained throughput, unit costs could stay elevated and keep EBITDA and cash flow under pressure."
Q3 backs up that concern. Harvest guidance for 2026 is cut to about 5,500 tonnes, with roughly 350 tonnes pushed into 2027, and group EBITDA remains a NOK 20m loss. Farming cost of around NOK 71/kg, well above the NOK 60 to 65/kg mid 2027 target, shows fixed cost dilution lagging the plan.
Hunt For Quiet Price Dislocations
Salmon Evolution shows how operations and earnings can advance on different schedules. The real opportunity is finding stocks that could be undervalued before the market adjusts their prices.
- Company 1 - 25% below our estimate - develops a cardiometabolic and obesity drug portfolio by expanding access and manufacturing capacity for incretin therapies.
- Company 2 - 40% below our estimate - expands coconut based beverage brands and private label offerings as retailers lean harder into this category across channels.
- Company 3 - 46% below our estimate - converts a large construction backlog and new mega-project wins into cash while working through costly legacy disputes and litigation.
That is three of the list. See the full list of 191 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com